Radioactive drug trial aims to control spreading prostate cancer
NCT ID NCT06894511
Summary
This study is testing whether adding a standard hormone therapy to a newer radioactive drug works better than the radioactive drug alone for men with advanced prostate cancer that has spread and is no longer responding to standard hormone treatments. The radioactive drug (lutetium vipivotide tetraxetan) seeks out and delivers radiation directly to prostate cancer cells. Researchers want to see if the combination helps control the cancer's growth and spread for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arizona Center for Cancer Care
Gilbert, Arizona, 85297, United States
-
Cancer And Blood Spclsts of AZ
Casa Grande, Arizona, 85122, United States
-
Cancer Specialists of North Florida
Jacksonville, Florida, 32256, United States
-
East Jefferson Hospital
Metairie, Louisiana, 70006, United States
-
Highlands Oncology Group
Fayetteville, Arkansas, 72703, United States
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Northwest Cancer Specialists
Portland, Oregon, 97210, United States
-
Texas Oncology P A
Bedford, Texas, 76022, United States
-
Univ Of Color Anschutz Med Center
Aurora, Colorado, 80045, United States
-
Urology Austin
Lakeway, Texas, 78738, United States
-
Urology Cancer Center PC
Omaha, Nebraska, 68130, United States
-
Urology San Antonio
San Antonio, Texas, 78229, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.